Search Results 291-300 of 17047 for monoclonal antibody
Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.
Monoclonal antibodies. The Food and Drug Administration (FDA) recently ... Dupilumab is a type of medicine known as a monoclonal antibody. It works to ...
Monoclonal antibodies, such as isatuximab, may ... Patients must not have any known allergies to isatuximab or other monoclonal antibody therapies.
... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. This medicine is available only under a restricted ...
Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. ... monoclonal antibody; Previous history of congestive heart failure ...
RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...
Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.